Molecules and Cells

Cited by CrossRef (21)

  1. Marjan Aghajani, Behzad Mansoori, Ali Mohammadi, Zahra Asadzadeh, Behzad Baradaran. New emerging roles of CD133 in cancer stem cell: Signaling pathway and miRNA regulation. Journal Cellular Physiology 2019;234:21642
    https://doi.org/10.1002/jcp.28824
  2. Wenying Zhang, Jing Liu, Qiongwei Wu, Yu Liu, Chengbin Ma, Prasanna Kumar Santhekadur. HOTAIR Contributes to Stemness Acquisition of Cervical Cancer through Regulating miR-203 Interaction with ZEB1 on Epithelial-Mesenchymal Transition. Journal of Oncology 2021;2021:1
    https://doi.org/10.1155/2021/4190764
  3. Jawad Fares, Deepak Kanojia, Alex Cordero, Ilya Ulasov, Maciej S. Lesniak. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies. 2021.
    https://doi.org/10.1016/B978-0-12-821567-8.00014-2
  4. Parisa Sahranavardfard, Javad Firouzi, Masoumeh Azimi, Pardis Khosravani, Raheleh Heydari, Amirnader Emami Razavi, Mahshad Dorraj, Faezeh Keighobadi, Marzieh Ebrahimi. MicroRNA‐203 reinforces stemness properties in melanoma and augments tumorigenesis in vivo. Journal Cellular Physiology 2019;234:20193
    https://doi.org/10.1002/jcp.28619
  5. Hung‐Tzi Lai, Wen‐Ko Tseng, Shi‐Wei Huang, Ta‐Chung Chao, Yeu Su. MicroRNA‐203 diminishes the stemness of human colon cancer cells by suppressing GATA6 expression. Journal Cellular Physiology 2020;235:2866
    https://doi.org/10.1002/jcp.29192
  6. Bhavesh K. Ahir, Howard Ozer, Herbert H. Engelhard, Sajani S. Lakka. MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review. Critical Reviews in Oncology/Hematology 2017;120:22
    https://doi.org/10.1016/j.critrevonc.2017.10.003
  7. Farzaneh Sharifzad, Saeid Ghavami, Javad Verdi, Soura Mardpour, Mahsa Mollapour Sisakht, Zahra Azizi, Adeleh Taghikhani, Marek J. Łos, Esmail Fakharian, Marzieh Ebrahimi, Amir Ali Hamidieh. Glioblastoma cancer stem cell biology: Potential theranostic targets. Drug Resistance Updates 2019;42:35
    https://doi.org/10.1016/j.drup.2018.03.003
  8. Ali Rajabi, Mehrdad Kayedi, Shiva Rahimi, Fatemeh Dashti, Seyed Mohammad Ali Mirazimi, Mina Homayoonfal, Seyed Mohammad Amin Mahdian, Michael R. Hamblin, Omid Reza Tamtaji, Ali Afrasiabi, Ameneh Jafari, Hamed Mirzaei. Non-coding RNAs and glioma: Focus on cancer stem cells. Molecular Therapy - Oncolytics 2022;27:100
    https://doi.org/10.1016/j.omto.2022.09.005
  9. Roger S. Holmes. Comparative studies of vertebrate iduronate 2-sulfatase (IDS) genes and proteins: evolution of A mammalian X-linked gene. 3 Biotech 2017;7
    https://doi.org/10.1007/s13205-016-0595-3
  10. Swalih P. Ahmed, Javier S. Castresana, Mehdi H. Shahi. Glioblastoma and MiRNAs. Cancers 2021;13:1581
    https://doi.org/10.3390/cancers13071581
  11. Alessio D’Alessio, Gabriella Proietti, Gigliola Sica, Bianca Maria Scicchitano. Pathological and Molecular Features of Glioblastoma and Its Peritumoral Tissue. Cancers 2019;11:469
    https://doi.org/10.3390/cancers11040469
  12. Malak Hassn Mesrati, Amir Barzegar Behrooz, Asmaa Y. Abuhamad, Amir Syahir. Understanding Glioblastoma Biomarkers: Knocking a Mountain with a Hammer. Cells 2020;9:1236
    https://doi.org/10.3390/cells9051236
  13. Omidvar Rezaei, Kasra Honarmand, Saeedeh Nateghinia, Mohammad Taheri, Soudeh Ghafouri-Fard. miRNA signature in glioblastoma: Potential biomarkers and therapeutic targets. Experimental and Molecular Pathology 2020;117:104550
    https://doi.org/10.1016/j.yexmp.2020.104550
  14. Diana, Gaido, Murtas. MicroRNA Signature in Human Normal and Tumoral Neural Stem Cells. IJMS 2019;20:4123
    https://doi.org/10.3390/ijms20174123
  15. Ava Nasrolahi, Shirin Azizidoost, Klaudia Radoszkiewicz, Sajad Najafi, Farhoodeh Ghaedrahmati, Omid Anbiyaee, Seyed Esmaeil Khoshnam, Maryam Farzaneh, Shahab Uddin. Signaling pathways governing glioma cancer stem cells behavior. Cellular Signalling 2023;101:110493
    https://doi.org/10.1016/j.cellsig.2022.110493
  16. Andrea Diana, Giuseppe Gaido, Cristina Maxia, Daniela Murtas. MicroRNAs at the Crossroad of the Dichotomic Pathway Cell Death vs. Stemness in Neural Somatic and Cancer Stem Cells: Implications and Therapeutic Strategies. IJMS 2020;21:9630
    https://doi.org/10.3390/ijms21249630
  17. Jian Chen, Li Yang, Xiongwei Wang. Reduced circulating microRNA-203 predicts poor prognosis for glioblastoma. CBM 2017;20:521
    https://doi.org/10.3233/CBM-170335
  18. Renhui Yi, Jiugeng Feng, Shaochun Yang, Xiaoyu Huang, Yuanyuan Liao, Zheng Hu, Muyun Luo. miR-484/MAP2/c-Myc-positive regulatory loop in glioma promotes tumor-initiating properties through ERK1/2 signaling. J Mol Hist 2018;49:209
    https://doi.org/10.1007/s10735-018-9760-9
  19. James N. Tsoporis, Amin M. Ektesabi, Sahil Gupta, Shehla Izhar, Vasileios Salpeas, Ioannis K. Rizos, Stylianos P. Kympouropoulos, Claudia C. dos Santos, Thomas G. Parker, Emmanouil Rizos. A longitudinal study of alterations of circulating DJ-1 and miR203a-3p in association to olanzapine medication in a sample of first episode patients with schizophrenia. Journal of Psychiatric Research 2022;146:109
    https://doi.org/10.1016/j.jpsychires.2021.12.049
  20. Hong-xiang Wang, Rong Qin, Jian Mao, Qi-lin Huang, Fan Hong, Feng Li, Zhen-yu Gong, Tao Xu, Yong Yan, Shao-hui Chao, Shi-kun Zhang, Ju-xiang Chen. CPEB4 regulates glioblastoma cell proliferation and predicts poor outcome of patients. Clinical Neurology and Neurosurgery 2018;169:92
    https://doi.org/10.1016/j.clineuro.2018.04.008
  21. M. Janaki Ramaiah, Karthikeyan Divyapriya, Sarwareddy Kartik Kumar, Y.B.R.D. Rajesh. Drug-induced modifications and modulations of microRNAs and long non-coding RNAs for future therapy against Glioblastoma Multiforme. Gene 2020;723:144126
    https://doi.org/10.1016/j.gene.2019.144126